Libro blanco de las ACES Pediátricas 2024

Libro Blanco de las ACES Pediátricas 2024 314 ❚ European Training Programme in Paediatric Haematology and Oncology    _________________________________________________________________________________________ SIOP Europe – March 2020 European Training Programme in Paediatric Haematology and Oncology Contents Background ......................................................................................................................................... 2 Update March 2020 ............................................................................................................................ 2 Module 1: Learning Points .................................................................................................................. 3 Module 2: Practical Activities.............................................................................................................. 4 DIAGNOSTIC AND THERAPEUTIC APPROACH ...........................................................................4 ADOLESCENTS / YOUNG ADULTS WITH CANCER ......................................................................4 MINIMUM NUMBER OF PROCEDURES TO BE PERFORMED ......................................................4 MINIMUM NUMBER OF PATIENTS TO BE EVALUATED .............................................................5 Module 3: Diagnosis, Treatment and Follow‐Up ................................................................................ 6 LEUKEMIA (ALL, AML)..............................................................................................................6 MDS and JMML .......................................................................................................................6 HODGKIN’S DISEASE ................................................................................................................6 NON‐HODGKIN’S LYMPHOMA .................................................................................................7 RENAL TUMORS ......................................................................................................................7 NEUROBLASTOMA...................................................................................................................7 BONE TUMORS........................................................................................................................8 SOFT TISSUE SARCOMA ...........................................................................................................8 CNS TUMORS ..........................................................................................................................9 RETINOBLASTOMA ..................................................................................................................9 HEPATIC TUMORS ...................................................................................................................9 NON‐INTRACRANIAL GERM CELL TUMOURS ..........................................................................11 HISTIOCYTOSES (LCH, RARE NON‐LCH AND HLH)....................................................................11 Module 4: Research Aspects............................................................................................................. 12 Module 5: Continuous Medical Education........................................................................................ 12 Module 6: Optional 3 rd  Year in a Specified Field:.............................................................................. 13 HAEMATOLOGICAL MALIGNANCIES.......................................................................................13 SOLID AND BRAIN TUMOURS ................................................................................................13 CELLULAR THERAPIES OTHER THAN STEM CELL TRANSPLANTATION ......................................13 Reviewed by:..................................................................................................................................... 14